Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127359271 | 12735927 | 1 | I | 20160831 | 20160913 | 20160913 | EXP | GB-APOTEX-2016AP011116 | APOTEX | 48.00 | YR | Y | 0.00000 | 20160913 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127359271 | 12735927 | 1 | PS | PERINDOPRIL 2 MG TABLETS | PERINDOPRIL | 1 | Unknown | 6 MG, QD | Y | 90463 | 6 | MG | TABLET | ||||||
| 127359271 | 12735927 | 2 | SS | INDAPAMIDE. | INDAPAMIDE | 1 | Unknown | 2.5 MG, QD | Y | 0 | 2.5 | MG | |||||||
| 127359271 | 12735927 | 3 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | 20 MG, QD | U | U | 0 | 20 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127359271 | 12735927 | 1 | Hypertension |
| 127359271 | 12735927 | 2 | Hypertension |
| 127359271 | 12735927 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127359271 | 12735927 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127359271 | 12735927 | Asthenia | |
| 127359271 | 12735927 | Dizziness | |
| 127359271 | 12735927 | Dysarthria | |
| 127359271 | 12735927 | Hyponatraemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |